Warm Autoimmune Hemolytic Anemia with Chronic Hepatitis B
DOI:
https://doi.org/10.32734/sumej.v7i1.11836Keywords:
Chronic Hepatitis B, Steroid, Warm AIHAAbstract
Warm autoimmune hemolytic anemia (wAIHA) is caused by erithrocytes destruction by IgG or IgG plus C3d-mediated autoantibody. Long use steroids are first line therapy of wAIHA. It has risk infection reactivation, like chronic hepatitis B. Man, 64 y.o, hospitalized with diagnosis wAIHA and chronic hepatitis B. Diagnosis of wAIHA is built by: severe normocytic normochromic anemia, reticulocytosis 42.29%, increasing lactate dehydrogenase 397 U/L, direct Coombs test (+4), antibody screening IgG (+4). Anothers laboratorium findings: HbsAg (+), albumin 3.5 g/dL, ALT U/L, rapid HIV (-), anti HCV (-). There is no blast found in peripheral blood and bone marrow smear. Patient also diagnosed chronic hepatitis B inactive phase with negative HbeAg, HBV DNA 547 IU/L, normal liver finding in abdominal USG and moderate fibrosis from fibroscan. Washed red cell transfussion was administered, 2 x 125 mg methilprednisolone iv (3 days) tapering off until to 40 mg/day doses. He did not get antiviral prophylaxis and be planned to reevaluate in next 6 months. Steroid is first line therapy in wAIHA. When wAIHA is diagnosed, determination of chronic hepatitis B status should confirmed. There is a risk of reactivation of chronic hepatitis B infection so monitoring is needed.
Downloads
References
Parjono E. et al (eds). Buku Ajar Ilmu Penyakit Dalam Volume VII. Jakarta: Interna Publishing. 2018;663–8.
Barcellini W, Zaninoni A, Giannotta A, et al. Review: New insights in autoimmune hemolytic anemia: from pathogenesis to therapy. Journal of Clinical Medicine. 2022;3859(9):1–19
Hill A, and Hill QA. Autoimmune hemoliytic anemia. Hemolytic Anemia: Cornucopia of causes. American Society of Hematology. 2018:382–9
Parjono E, et al (eds). Buku Ajar Ilmu Penyakit Dalam Volume VII. Jakarta: Interna Publishing. 2018;632–5
Zanella A, and Barcellini W. Review: Treatment of autoimmune hemolytic anemias. Haematologica. 2014;99(10):1547–54
Perhimpunan Peneliti Hati Indonesia. Konsensus Nasional Penatalaksanaan Hepatitis B. Jakarta: Perhati. 2018.
Hatano M, Mimura T, Shimada A, et al. Original article: Hepatitis B virus reactivation with corticosteroid therapy in patiens with adrenal insuficiency. Endocrinology, Diabetes & Metabolism. 2019;2:1–7.
Zhong Z, Liao W, Dai L, et al. Average corticosteroid dose and risk for HBV reactivation and hepatitis flare in patients with resolved hepatitis B infection. Annals of the Rheumatic Diseases. 2022;81:584–91.
Jeong W, Choe JY, Song BC, et al. Effect of low dose corticosteroid use on HBV reactivation in HbsAg positive rheumatoid arthritis patient. 2021.
Published
How to Cite
Issue
Section
Copyright (c) 2024 Sumatera Medical Journal
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The Authors submitting a manuscript do so on the understanding that if accepted for publication, copyright of the article shall be assigned to Sumatera Medical Journal (SUMEJ) and Faculty of Medicine as well as TALENTA Publisher Universitas Sumatera Utara as publisher of the journal.
Copyright encompasses exclusive rights to reproduce and deliver the article in all form and media. The reproduction of any part of this journal, its storage in databases and its transmission by any form or media, will be allowed only with a written permission from Sumatera Medical Journal (SUMEJ).
The Copyright Transfer Form can be downloaded here.
The copyright form should be signed originally and sent to the Editorial Office in the form of original mail or scanned document.